Navigation Links
Ardea Biosciences to Present at Four Upcoming Investor Conferences
Date:9/13/2010

SAN DIEGO, Sept. 13 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that the Company will present at the following upcoming investor conferences:

  • Stifel Nicolaus 2010 Healthcare Conference in Boston, Massachusetts.  Stephen R. Davis, Executive Vice President and Chief Operating Officer will present at 10:20 a.m. EDT on Thursday, September 16, 2010. This presentation will be webcast and can be accessed on Ardea's website at www.ardeabio.com in the Investor Relations section under News & Events.  
  • Bank of America Merrill Lynch Global Healthcare Conference in London, England.  Barry D. Quart, Pharm.D., President and Chief Executive Officer will present at 1:45 p.m. BST on Thursday, September 16, 2010.
  • UBS 2010 Global Life Sciences Conference in New York, NY.  Barry D. Quart, Pharm.D., President and Chief Executive Officer will present at 8:00 a.m. EDT on Monday, September 20, 2010. This presentation will be webcast and can be accessed on Ardea's website at www.ardeabio.com in the Investor Relations section under News & Events.
  • Fifth Annual JMP Securities Healthcare Conference in New York, NY.  Barry D. Quart, Pharm.D., President and Chief Executive Officer will present at 8:30 a.m. EDT on Monday, September 27, 2010. This presentation will be webcast and can be accessed on Ardea's website at www.ardeabio.com in the Investor Relations section under News & Events.

About Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases.  RDEA594, our lead product candidate fo
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
10. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
11. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Pete Rose, baseball,s all-time hits ... and arthritis pain reliever Myoflex, Ducere Pharma has announced. ... we are excited to have him on board with Myoflex," ... "He is a legendary player who is known across all ...
(Date:1/23/2015)... Fla. , Jan. 23, 2015  iMD Companies, Inc. (ICBU) ... to increase market share and grab a foothold in the ... influence, production capabilities and a presence in the sector, and ... facilitate the growth of hemp and medical marijuana, iMD is ...
(Date:1/23/2015)... 2015   Leatt Corporation  (OTCQB: LEAT), a global developer, ... forms of sports, including extreme motor sports, and whose ... that the UISP Lega Motociclismo Lombardia, an Italian motocross ... wear a neck brace during its racing competitions.  ...
Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3
... N.J., Oct. 12, 2011 Savient Pharmaceuticals, Inc. (NASDAQ: ... financial results for the third quarter 2011 prior to the ... John H. Johnson, Chief Executive Officer and President, ... Officer, will host an investment community conference call beginning at ...
... 12, 2011 If you could learn that you have a ... and 75 percent of that chance could be altered by lifestyle ... of the nation,s leading online direct-to-consumer online lab test and health ... Your Number HealthScore as seen on The Biggest Loser ...
Cached Medicine Technology:Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011 2PersonaLabs and BioSignia Join to Offer Targeted Risk Assessment 2
(Date:1/22/2015)... The City of West Hollywood hosted a news conference ... 42nd anniversary of the Supreme Court decision Roe v. Wade, which ... since the Roe vs. Wade decision and the fight to protect ... said City of West Hollywood Councilmember Abbe Land. “We need to ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together by ... up to 30lbs in less than 12 weeks without traditional ... prompting an investigative review. , “Our Incredible Bulk review ... that allows the body to pack on a massive amount ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Juvent Sports ... at the 2015 PGA Merchandise Show to bestow a ... incredible female amateur golfer, Arlene McKitrick. The award commemorated ... amateur golf tournament win. She won her first amateur ...
(Date:1/22/2015)... released a new blog post presenting the basic features of ... an accidental death and dismemberment rider for a car insurance ... benefits if the insured dies in an accident. Accidental death ... insurance. , AD&D is not expensive and can be ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... July 8 Governor Edward G.,Rendell today issued ... Containment Council (PHC4), which closed after the law,authorizing ... Governor acted similarly in 2003, when PHC4 was ... later reauthorized by legislative action., The Rendell ...
... Study Validates Use of Pharos Innovation,s Proprietary,Device-Free Remote Monitoring Platform ... ... Medical Costs, NORTHFIELD, Ill., July 8 ... generation clinical and financial,performance improvement through a device-free remote monitoring ...
... Barbara Ann Karmanos,Cancer Center announced that it has ... lease space and equipment at the Meadowbrook Medical,Center, ... foot,space will allow Karmanos to expand its outreach ... as well as provide access to radiation,oncology, medical ...
... single nucleotide polymorphisms (SNPs), that are associated with a ... breast cancer do not appear to substantially improve the ... predict an individual,s risk, according to a study in ... of the National Cancer Institute . , Risk prediction ...
... PITTSBURGHUniversity of Pittsburgh-led researchers could provide new insight ... deformity and arteriovenous malformations (AVMs)develop in humans, as ... Developmental Biology . , Led by Beth Roman, ... School of Arts and Sciences, the team created ...
... yet to show drop-off in access predicted by critics ... have not lost access to care despite federal legislation ... years, a new report finds. , Critics feared the ... make treatment more difficult, but investigators from the Duke ...
Cached Medicine News:Health News:Governor Rendell Issues Executive Order Regarding Pennsylvania Health Care Cost Containment Council 2Health News:Governor Rendell Issues Executive Order Regarding Pennsylvania Health Care Cost Containment Council 3Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3Health News:Karmanos Cancer Center Partners With Meadowbrook to Expand Outreach and Access for Cancer Services 2Health News:Single-nucleotide polymorphisms do not substantially improve risk prediction for breast cancer 2Health News:Pitt-led research provides insight into development of congenital circulatory defects 2Health News:Cancer Care Unaffected by Doctor Reimbursement Changes 2
Terumo's Outlook offers superior torque and precision control. It's patient-friendly, high torque design makes it the catheter of choice for demanding angiography....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
... INFINITI 4F, 5F, and ... catheters is ideal for ... incorporate state-of-the-art technology and ... deliver better responsiveness, optimal ...
Medicine Products: